Yoshihiro Aiba

1.5k citations

36 papers · 613 indexed · h-index 16

Co-authors: Minoru Nakamura Atsumasa Komori Kiyoshi Migita Hiromi Ishibashi Hiroshi Yatsuhashi Katsushi Tokunaga Minae Kawashima Nao Nishida
Topics: Liver Diseases and Immunity (18 papers)Liver Disease Diagnosis and Treatment (14 papers)T-cell and B-cell Immunology (8 papers)
Cited by: Hepatology Immunology Rheumatology
Journals: Hepatology Scientific Reports FEBS Letters
Partner nations: Japan Singapore United Kingdom

In The Last Decade

Yoshihiro Aiba

35 papers receiving 604 citations

Peers

Countries citing papers authored by Yoshihiro Aiba

Since Specialization

Citations

This map shows the geographic impact of Yoshihiro Aiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Aiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Aiba more than expected).

Fields of papers citing papers by Yoshihiro Aiba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Aiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Aiba. The network helps show where Yoshihiro Aiba may publish in the future.

Co-authorship network of co-authors of Yoshihiro Aiba

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Aiba. A scholar is included among the top collaborators of Yoshihiro Aiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Aiba. Yoshihiro Aiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel HLA allele associations with susceptibility, staging, symptomatic state, autoimmune hepatitis and hepatocellular carcinoma events for primary biliary cholangitis in the Japanese population 2023 ·Frontiers in Immunology ·Seik‐Soon Khor,Kazuko Ueno,Nao Nishida,Minae Kawashima,Yosuke Kawai,Yoshihiro Aiba,Yuki Hitomi,Masao Nagasaki,Minoru Nakamura,Katsushi Tokunaga	5
2	rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis 2021 ·Journal of Autoimmunity ·Yuki Hitomi,Yoshihiro Aiba,Kazuko Ueno,Nao Nishida,Yosuke Kawai,Minae Kawashima,Michio Yasunami,(unknown),Masahiro Ito,Heather J. Cordell,George Mells,Masao Nagasaki,Katsushi Tokunaga,Makoto Tsuiji,Minoru Nakamura	7
3	Increased expression and altered localization of cathepsin Z are associated with progression to jaundice stage in primary biliary cholangitis 2018 ·Scientific Reports ·Yoshihiro Aiba,Kenichi Harada,Masahiro Ito,Takashi Suematsu,Shinichi Aishima,Yuki Hitomi,Nao Nishida,Minae Kawashima,Mitsuhisa Takatsuki,Susumu Eguchi,Shinji Shimoda,Hitomi Nakamura,Atsumasa Komori,Seigo Abiru,Shinya Nagaoka,Kiyoshi Migita,Hiroshi Yatsuhashi,Katsushi Tokunaga,Minoru Nakamura	7
4	Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1 2015 ·Human Genetics ·Yuki Hitomi,Minae Kawashima,Yoshihiro Aiba,Nao Nishida,(unknown),Hitoshi Okazaki,Minoru Nakamura,Katsushi Tokunaga	18
5	Suppression of immunoglobulin production in human peripheral blood mononuclear cells by monocytes via secretion of heavy-chain ferritin 2013 ·Immunobiology ·Makiko Yamashita,(unknown),Shin‐ei Matsumoto,Yoshihiro Aiba,Akira Ichikawa,Tsukasa Fujiki,Miyako Udono,Shigeru Kabayama,Tadashi Yoshida,Pingbo Zhang,Hiroshi Fujii,Sanetaka Shirahata,Yoshinori Katakura	11
6	Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients 2013 ·Journal of Gastroenterology ·(unknown),(unknown),Makoto Nakamuta,Naoko Ishikawa,Ohki Saitoh,Hitomi Nakamura,Yoshihiro Aiba,Atsumasa Komori,Kiyoshi Migita,Hiroshi Yatsuhashi,Nobuyoshi Fukushima,Motoyuki Kohjima,Tsuyoshi Yoshimoto,Kunitaka Fukuizumi,Mākoto Ishibashi,Takashi Nishino,Ken Shirabe,Akinobu Taketomi,Yoshihiko Maehara,(unknown),Minoru Nakamura	14
7	Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes 2012 ·Modern Rheumatology ·(unknown),Takafumi Torigoshi,Tomohiro Koga,Yümi Maeda,Yasumori Izumi,Yuka Jiuchi,Taiichiro Miyashita,Satoshi Yamasaki,Atsushi Kawakami,Yoshihiro Aiba,Minoru Nakamura,Atsumasa Komori,(unknown),Hiromi Ishibashi,Satoru Motokawa,Kiyoshi Migita	19
8	Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts 2012 ·Arthritis Research & Therapy ·Kiyoshi Migita,Tomohiro Koga,(unknown),Masahiro Izumi,Takafumi Torigoshi,Yümi Maeda,Yasumori Izumi,Yuka Jiuchi,Taiichiro Miyashita,Satoshi Yamasaki,Yoshihiro Aiba,Atsumasa Komori,Minoru Nakamura,Satoru Motokawa,Atsushi Kawakami,Tadashi Nakamura,Hiromi Ishibashi	25
9	Inhibitory effects of the JAK inhibitor CP690,550 on human CD4+ T lymphocyte cytokine production 2011 ·BMC Immunology ·Kiyoshi Migita,Taiichiro Miyashita,Yasumori Izumi,Tomohiro Koga,Atsumasa Komori,Yümi Maeda,Yuka Jiuchi,Yoshihiro Aiba,Satoshi Yamasaki,Atsushi Kawakami,Minoru Nakamura,Hiromi Ishibashi	23
10	Analysis of HLA‐DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA‐DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC 2010 ·Hepatology Research ·Minoru Nakamura,Michio Yasunami,Hisayoshi Kondo,(unknown),Yoshihiro Aiba,Atsumasa Komori,Kiyoshi Migita,Hiroshi Yatsuhashi,Masahiro Ito,Shinji Shimoda,Hiromi Ishibashi,(unknown)	42
11	Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers 2008 ·Hepatology International ·Minoru Nakamura,Kenji Funami,Atsumasa Komori,Terufumi Yokoyama,Yoshihiro Aiba,(unknown),Yasushi Takii,Masahiro Ito,Mutsumi Matsuyama,Makiko Koyabu,Kiyoshi Migita,Ken Taniguchi,Hikaru Fujioka,Hiroshi Yatsuhashi,Misako Matsumoto,Hiromi Ishibashi,Tsukasa Seya	29
12	A rapid and efficient strategy to generate antigen-specific human monoclonal antibody by in vitro immunization and the phage display method 2008 ·Journal of Immunological Methods ·Shin‐ei Matsumoto,Makiko Yamashita,Yoshinori Katakura,Yoshihiro Aiba,Kosuke Tomimatsu,Shigeru Kabayama,Kiichiro Teruya,Sanetaka Shirahata	13
13	Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis 2008 ·Hepatology ·(unknown),Minoru Nakamura,(unknown),(unknown),(unknown),Yoshihiro Aiba,Atsumasa Komori,Katsuhisa Omagari,Hiromi Ishibashi,Kazuhiro Tsukamoto	23
14	Serum amyloid A‐induced IL‐6 production by rheumatoid synoviocytes 2008 ·FEBS Letters ·Tomohiro Koga,Takafumi Torigoshi,Satoru Motokawa,Taichiro Miyashita,Yümi Maeda,Minoru Nakamura,Atsumasa Komori,Yoshihiro Aiba,Takashi Uemura,Hiroshi Yatsuhashi,Hiromi Ishibashi,Katsumi Eguchi,Kiyoshi Migita	53
15	Involvement of IL-10 in the suppression of antibody production by in vitro immunized peripheral blood mononuclear cells 2007 ·Cytotechnology ·Makiko Yamashita,Yoshinori Katakura,Yoshihiro Aiba,Shin‐ei Matsumoto,(unknown),Kiichiro Teruya,Akira Ichikawa,Sanetaka Shirahata	0
16	Predictive role of anti‐gp210 and anticentromere antibodies in long‐term outcome of primary biliary cirrhosis 2007 ·Hepatology Research ·Minoru Nakamura,Atsumasa Komori,Masahiro Ito,Hisayoshi Kondo,Yoshihiro Aiba,Kiyoshi Migita,Shinya Nagaoka,Kazuyuki Ohata,Koji Yano,Seigo Abiru,Manabu Daikoku,Hiroshi Yatsuhashi,Shinji Shimoda,Hiromi Ishibashi	27
17	Anti-Peptide Antibody Production Elicited byin VitroImmunization of Human Peripheral Blood Mononuclear Cells 2007 ·Bioscience Biotechnology and Biochemistry ·Takashi Tamura,Kosuke Tomimatsu,Yoshinori Katakura,Makiko Yamashita,Shin‐ei Matsumoto,Yoshihiro Aiba,(unknown),(unknown),Tsukasa Fujiki,Kiichiro Teruya,Sanetaka Shirahata	8
18	Identification of Genes Involved in the Suppression of Antibody Production from Human Peripheral Blood Lymphocytes 2006 ·Bioscience Biotechnology and Biochemistry ·Yoshihiro Aiba,Makiko Yamashita,Yoshinori Katakura,(unknown),Shin‐ei Matsumoto,(unknown),Kiichiro Teruya,Sanetaka Shirahata	1
19	IL-10 Augments Antibody Production inin VitroImmunized Lymphocytes by Inducing a Th2-Type Response and B Cell Maturation 2004 ·Bioscience Biotechnology and Biochemistry ·Qianghua Xu,Yoshinori Katakura,Makiko Yamashita,(unknown),Takashi Tamura,Shin‐ei Matsumoto,Yoshihiro Aiba,Kiichiro Teruya,Kazuhiro Osada,(unknown),Sanetaka Shirahata	34
20	Different individual immune responses elicited by in vitro immunization 2002 ·Cytotechnology ·Makiko Yamashita,Yoshinori Katakura,(unknown),Shin‐ei Matsumoto,Takashi Tamura,(unknown),Yoshihiro Aiba,Kiichiro Teruya,Toshie Tsuchiya,Sanetaka Shirahata	14

About Yoshihiro Aiba

Yoshihiro Aiba is a scholar working on Hepatology, Immunology and Epidemiology, having authored 36 papers that have together received 613 indexed citations. Recurring topics across this work include Liver Diseases and Immunity (18 papers), Liver Disease Diagnosis and Treatment (14 papers) and T-cell and B-cell Immunology (8 papers). The work is most often cited by research in Hepatology (184 citations), Immunology (211 citations) and Rheumatology (110 citations). Yoshihiro Aiba has collaborated with scholars based in Japan, Singapore and United Kingdom. Frequent co-authors include Minoru Nakamura, Atsumasa Komori, Kiyoshi Migita, Hiromi Ishibashi, Hiroshi Yatsuhashi, Katsushi Tokunaga, Minae Kawashima, Nao Nishida, Tomohiro Koga and Yuki Hitomi. Their work appears in journals such as Hepatology, Scientific Reports and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact